Cargando…
Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
BACKGROUND: In developing countries, intravenous thrombolysis (IVT) is available at a limited number of centers. This study aimed to assess the feasibility and safety of IVT at Tabriz Imam Reza Hospital. METHODS: In a prospective study, over a 55-month period, any patient at the hospital for whom st...
Autores principales: | Sadeghi-Hokmabadi, Elyar, Farhoudi, Mehdi, Taheraghdam, Aliakbar, Hashemilar, Mazyar, Savadi-Osguei, Daryous, Rikhtegar, Reza, Mehrvar, Kaveh, Sharifipour, Ehsan, Youhanaee, Parisa, Mirnour, Reshad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087792/ https://www.ncbi.nlm.nih.gov/pubmed/27822079 http://dx.doi.org/10.2147/IJGM.S112430 |
Ejemplares similares
-
Simple In-Hospital Interventions to Reduce Door-to-CT Time in Acute Stroke
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016) -
Renal Dysfunction Is an Independent Risk Factor for Poor Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis: A New Cutoff Value
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2017) -
Effect of IMOD(™) on the inflammatory process after acute ischemic stroke: a randomized clinical trial
por: Farhoudi, Mehdi, et al.
Publicado: (2013) -
Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2018) -
Early and intermediate prognosis of intravenous thrombolytic therapy in acute ischemic stroke subtypes according to the causative classification of stroke system
por: Pashapour, Ali, et al.
Publicado: (2013)